Marketing image of Diabeloop DBLG1 automated insulin delivery system
The DBLG1 automated insulin delivery system [Image from Diabeloop]

Diabeloop today announced 12-month data supporting its hybrid closed-loop DBLG1 automated insulin delivery system.

Paris-based Diabeloop evaluated DBLG1 in a large, multi-country patient cohort. Results demonstrated constant improvement in time in range and time in hypoglycemia remaining significantly low.

Get the full story at our sister site, Drug Delivery Business News.